Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fuzhou Haiwang Jinxiang Traditional Chinese Medicine Pharmaceutical is a specialized manufacturer of Traditional Chinese Medicine (TCM) based in Fuzhou, China. As a key subsidiary of the Neptunus Group (Shenzhen Neptunus Bioengineering), the company leverages extensive resources for the production of high-quality herbal pharmaceuticals. The company's product portfolio includes a wide range of dosage forms such as granules, capsules, tablets, and oral liquids, primarily focusing on pediatric, respiratory, and cardiovascular indications. Its flagship products, including Xiao'er Kechuanling and Fufang Danshen, are well-established brands within the Chinese domestic market. The firm operates modern, GMP-certified manufacturing facilities that integrate traditional herbal processing with contemporary pharmaceutical technology. Originally founded in 1958 as the Fuzhou Jinxiang Pharmaceutical Factory, the company has evolved into a modernized TCM enterprise through strategic restructuring and investment.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fuzhou Haiwang Jinxiang Traditional Chinese Medicine Pharmaceutical.